
Bifurcation Stenting Using Bioresorbable Vascular Scaffold in an Adult Male With Radiation-Induced Coronary Artery Disease and Hodgkin Lymphoma: A Case Report
More Info
Jonald O. Lucero, MD | Jeffrey De Jesus, MD | Jose Nicholas Cruz, MD | Richard Henry Tiongco, MD
St Luke’s Medical Center–Global City, Taguig, Metro Manila
- Fajardo LF. Is the pathology of radiation injury different in small vs large blood vessels? Cardiovasc Radiat Med 1999;1:108–110.
- Yusuf SW, Sami S, Daher IN. Radiation-induced heart disease: a clinical update. Cardiol Res Pract 2011;2011, Article ID 317659. https://doi.org/10.4061/2011/317659.
- Russell NS, Hoving S, Heeneman S, et al. Insights into pathological changes in muscular arteries of radiotherapy patients. Radiother Oncol 2009;92:477–483.
- Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 366:2087.
- Marks LB. Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys 2010;76(3 suppl):S10–S19. Radiation Oncology/Toxicity/QUANTEC 2010 PMID 20171502.
- Principles and Practice of Modern Radiotherapy Techniques in Breast Cancer. 2013.
- Schultz-Hector S, Trott KR. Radiation-induced cardiovascular diseases: is the epidemiologic evidence compatible with the radiobiologic data? Int J Radiat Oncol Biol Phys 2007;67:10–18.
- Ewer MS, Ewer SM. Cardiotoxicity of anticancer treatments: what the cardiologist should know: radiation induced heart disease. Nat Rev Cardiol 2010;7:564–575.
- Teles RC, Pereira H, Cyrne de Carvalho H, et al. Position statement on bioresorbable vascular scaffolds in Portugal [in Portuguese]. Rev Port Cardiol. 2013;32:1013–8.
- Zhao W, Diz DI, Robbins ME. Oxidative damage pathways in relation to normal tissue injury. Br J Radiol 2007;80 (spec no 1):S23–S33.
- http://www.nature.com/nrclinonc/journal/v5/n11/full/ ncponc1225.html.
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0
International License, which permits use, share — copy and redistribute the material in any medium or format,
adapt — remix, transform, and build upon the material, as long as you give appropriate credit,
provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner,
but not in any way that suggests the licensor endorses you or your use. You may not use the material for
commercial purposes. If you remix, transform, or build upon the material, you must distribute your
contributions under the same license as the original. You may not apply legal terms or technological
measures that legally restrict others from doing anything the license permits. The images or other
third party material in this article are included in the article’s Creative Commons license, unless indicated
otherwise in a credit line to the material. If material is not included in the article’s Creative Commons
license and your intended use is not permitted by statutory regulation or exceeds the permitted use,
you will need to obtain permission directly from the copyright holder. To view a copy of this license,
visit https://creativecommons.org/licenses/by-nc-sa/4.0/.